Unveiling the KDM3A/METTL16/PDK1 Axis: A Promising Prognostic Biomarker and Therapeutic Target for Overcoming TKI-Resistant Lung Cancer
Lung cancer remains the preeminent cause of cancer mortality worldwide, presenting formidable challenges to modern oncology, particularly in patients harboring ...
